CNMD CONMED Corp

  1. Stocks
  2. Healthcare
  3. NYSE: CNMD

Price (delayed)

$46.3

Market cap

$1.39B

P/E Ratio

25.03

Dividend/share

$0.8

EPS

$1.85

Enterprise value

$2.18B

?
Relative Growth: Rel. Growth: 49
Relative Strength: Rel. Strength: 62
Relative Valuation: Rel. Valuation: 59
Relative Profitability: Rel. Profitability: 48

CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties ...

Highlights
The company's debt fell by 5% YoY and by 3.1% QoQ
CNMD's equity is up by 3.8% YoY and by 2.3% from the previous quarter
The net income has declined by 49% year-on-year but it is up by 3% since the previous quarter
CNMD's EPS is down by 48% YoY but it is up by 4.5% QoQ
CNMD's quick ratio is down by 33% YoY and by 32% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.conmed.com
Peers: BSX MDT TFX SYK

Key stats

What are the main financial stats of CNMD

CNMD stock price

How has the CONMED stock price performed over time
Intraday
-1.45%
1 week
8.48%
1 month
41.46%
1 year
-9.48%
YTD
14.04%
QTD
41.46%

Financial performance

How have CONMED's revenue and profit performed over time
Revenue
$1.37B
Gross profit
$765.31M
Operating income
$110.32M
Net income
$56.5M
Gross margin
55.8%
Net margin
4.1%
The company's net margin has shrunk by 51% YoY but it rose by 2.5% QoQ
The net income has declined by 49% year-on-year but it is up by 3% since the previous quarter
The operating margin has declined by 38% year-on-year and by 2.4% since the previous quarter
The operating income has declined by 36% year-on-year

Price vs fundamentals

How does CNMD's price correlate with its fundamentals

Growth

What is CONMED's growth rate over time

Valuation

What is CONMED stock price valuation
CNMD P/E details
P/E
25.03
P/B
1.34
P/S
1.01
EV/EBIT
19.3
EV/EBITDA
16.82
EV/Sales
1.59
CNMD's EPS is down by 48% YoY but it is up by 4.5% QoQ
The stock's price to earnings (P/E) is 26% less than its 5-year quarterly average of 34.0 but 15% more than its last 4 quarters average of 21.8
The stock's price to book (P/B) is 57% less than its 5-year quarterly average of 3.1 but 12% more than its last 4 quarters average of 1.2
CNMD's equity is up by 3.8% YoY and by 2.3% from the previous quarter
CNMD's P/S is 54% less than its 5-year quarterly average of 2.2 but 12% more than its last 4 quarters average of 0.9
CNMD's revenue is up by 3.4% year-on-year

Efficiency

How efficient is CONMED business performance
The ROE has plunged by 52% YoY
CNMD's return on assets has dropped by 50% year-on-year
CNMD's ROS is down by 37% YoY
CNMD's return on invested capital is down by 30% year-on-year but it is up by 5% since the previous quarter

Dividends

What is CNMD's dividend history
Dividend details
DPS
$0.8
Dividend yield
1.73%
Payout ratio
43.2%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did CONMED financials performed over time
CNMD's total assets is 83% greater than its total liabilities
The current ratio has contracted by 35% from the previous quarter and by 34% YoY
CNMD's quick ratio is down by 33% YoY and by 32% QoQ
The company's debt is 20% lower than its equity
The company's debt to equity fell by 9% YoY and by 6% QoQ
The company's debt fell by 5% YoY and by 3.1% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.